This compound is a pharmaceutical intermediate featuring a purine nucleoside analog structure with a benzamide substituent and a methoxyethoxy side chain. It is primarily used in the manufacturing of nucleoside analog pharmaceuticals.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 333335-93-6
N6-BENZOYL-2'-O-METHYL-ADENOSINE
pharmaceutical intermediate
N-Benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-(2-methoxyethyl)adenosine
pharmaceutical intermediate
Bz-2'-F-dA
research compound
N-Benzoyl-2'-O-(2-methoxyethyl)-5-methylcytidine
pharmaceutical intermediate
2-Amino-6-fluoropurine
pharmaceutical intermediate
2-(Hydroxymethyl)-6-imino-7-methyl-2,3,3a,9a-tetrahydro-6H-furo[2',3':4,5][1,3]oxazolo[3,2-a]pyrimidin-3-ol--hydrogen chloride (1/1)
pharmaceutical intermediate
4,6-Dichloro-1-(2,3,5-tri-O-acetyl-beta-L-ribofuranosyl)-1H-imidazo[4,5-c]pyridine
pharmaceutical intermediate
Fmoc-D-Lys(Dde)-OH
pharmaceutical intermediate
N-[9-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-(2-methoxyethoxy)oxolan-2-yl]purin-6-yl]benzamide
RUFJMCSVNNGZFB-KHTYJDQRSA-N
COCCO[C@@H]1[C@@H]([C@H](O[C@H]1N2C=NC3=C(N=CN=C32)NC(=O)C4=CC=CC=C4)CO)O
—